[A05-19C] Memantine in Alzheimer's disease

Last updated 26.04.2011

Project no.:
A05-19C

Commission:
Commission awarded on 22.02.2005 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Head and nerves

26.04.2011

Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine

Change in the IQWiG final report of 2009: proof of a benefit for cognitive function; indications of a benefit for activities of da...

02.08.2010

Memantine in Alzheimer’s disease: reliable analyses are required

IQWiG supplements benefit assessment with previously unpublished studies

Accompanying information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealth.org.

Contact

Info Service

Subscribe to daily updated information on projects, calls for tender, and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.